Lv2
138 积分 2024-11-22 加入
Pharmacovigilance insights into drug-induced hypercalcemia: evidence from the U.S. FDA Adverse Event Reporting System (FAERS) database
6天前
已完结
Real-world evidence supporting the consensus-driven DILI control compounds list: An analysis of FAERS data
7天前
已完结
Trailblazing real-world-data to confront hepatocellular carcinoma - disinterring repurposable drugs by amalgamating avant-garde stratagems
7天前
已完结
Drug-induced nephrolithiasis: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System
8天前
已完结
Pharmacovigilance study and development of a clinical decision flowchart for personalized selection of trastuzumab, T-DXd, and T-DM1 in breast cancer patients
10天前
已完结
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal nanoparticle-formulated and conventional anticancer irinotecan
10天前
已完结
Disproportionality analysis of adverse events associated with degarelix: a real-world study from the FDA Adverse Event Reporting System (FAERS) database
10天前
已完结
Activity-based funding reform and the performance of public hospitals: The case of Queensland, Australia
15天前
已完结
Assessing the real-world safety of sparsentan for immunoglobulin A nephropathy: insights from a comprehensive analysis of FAERS database
20天前
已完结
皖公网安备34019202002308
